Favezelimab (Biosimilar Reference Antibody) (LAG3)
Favezelimab (Biosimilar Reference Antibody) (LAG3)
Favezelimab (Biosimilar Reference Antibody) (LAG3)-RA0453-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.
ELISA plate pre-coated Antigen protein, can bind Favezelimab (Biosimilar Reference Antibody) (LAG3)-RA0453 in a linear range of 3.91-125 ng/mL.
Favezelimab (Biosimilar Reference Antibody) (LAG3)

Catalog: 

RA0453

Target

LAG3/CD223

Isotype

IgG4 - kappa

Applications

ELISA;FC;Functional Assays;IF

Reactivities

Human

Size ($):

100 μg-50;1 mg-210;5 mg-500;10 mg-800;25 mg-1750;50 mg-3000;100 mg-4600

Data Sheet

Material Safety Data Sheet

Certificate of Analysis

Product Description

Favezelimab (development code MK-4280) is an investigational, humanized monoclonal IgG4 antibody being developed for cancer immunotherapy. It functions as an antagonist of the Lymphocyte Activation Gene-3 (LAG-3) immune checkpoint. By binding with high affinity to LAG-3 on the surface of T cells and other immune cells, favezelimab blocks its interaction with major histocompatibility complex class II (MHC-II) molecules and other potential ligands. This blockade releases the inhibitory "brake" that LAG-3 imposes on T-cell activation, proliferation, and effector function, thereby aiming to restore and enhance anti-tumor immune responses, particularly in T cells that are exhausted or dysfunctional. Its IgG4 isotype is chosen to minimize effector functions that could deplete immune cells.

Synonyms

MK-4280

CAS

2231068-83-8

Isotype

IgG4 - kappa

Host

Humanised

Target

LAG3/CD223

Reactivity

Human

Expression System

CHO

Applications

ELISA, FC, Functional Assays, IF; Recommended dilution: FC, IF:1:200

Purity

>98% by SDS-PAGE

Concentration

Bottled at the concentration indicated on the vial.

Buffer

0.01M PBS, pH 7.4, contains no stabilizers or preservatives.

Endotoxin

<1.0 EU/mg as determined by LAL method

Conjugation

Non-conjugated

Formulation

Liquid or Lyophilized powder Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.

Storage

store at -20°C or -80°C. Avoid repeated freeze.

Type

Antibody

Purposes

For research use only

References 1

Carmen Belli, et al. Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies. Cancers (Basel). 2022 Sep 1;14(17):4278.

References 2

Gareth P. Gregory, et al. Abstract CT106: Anti-LAG-3 antibody MK-4280 in combination with pembrolizumab for the treatment of hematologic malignancies: A Phase I/II study.  Cancer Res (2019) 79 (13_Supplement): CT106.

References 3

References 4

References 5

Product Citations 1

Product Citations 2

https://pubmed.ncbi.nlm.nih.gov/36077813/
https://aacrjournals.org/cancerres/article/79/13_Supplement/CT106/637738/Abstract-CT106-Anti-LAG-3-antibody-MK-4280-in
https://www.oursmab.com/News/The-immune-checkpoint-LAG-3.html

Target Description

Synonyms

lymphocyte activating 3, lymphocyte-activation 3, CD223

Biology Area

Immune Checkpoint;Immunology;CD Markers

Function

Lymphocyte Activation Gene-3 (LAG-3), also known as CD223. LAG-3 is a type I transmembrane protein and a member of the immunoglobulin superfamily, structurally related to CD4. It is expressed on activated and exhausted CD4+ and CD8+ T cells, regulatory T cells (Tregs), and some NK cells. LAG-3 acts as a co-inhibitory immune checkpoint receptor. Its binding to MHC-II molecules on antigen-presenting cells (APCs) or tumor cells delivers a potent negative signal that suppresses T-cell receptor (TCR) signaling, cytokine production, and T-cell proliferation. LAG-3 is frequently co-expressed with PD-1 on exhausted T cells within the tumor microenvironment, contributing to tumor immune escape.

Additional Articles 1

The-immune-checkpoint-LAG-3

Additional Articles 2

Related Products

Catalog: 

RA0453

Target:

CD274/PDL1/B7H1

Isotype:

IgG - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0453

Target:

IL6R/CD126

Isotype:

IgG1 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0453

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0453

Target:

IL7R/CD127

Isotype:

IgG1 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0453

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0453

Target:

IL7R/CD127

Isotype:

IgG4 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0453

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0453

Target:

Zaire Ebolaviru...

Isotype:

IgG1 - kappa

Applications:

Functional Assays

Reactivities:

Virus

Catalog: 

RA0453

Target:

IL9

Isotype:

IgG1 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Catalog: 

RA0453

Target:

ILDR2

Isotype:

IgG2 - kappa

Applications:

ELISA;FC;Functional Assays;IF

Reactivities:

Human

Contact Us

Send your request

Talk to us 

Get a quotation, discuss your requirement, receive advises from our antibody experts without obligation.